BASF has signed a definitive agreement with Catexel for the sale of its optical brightening agent business, a key ingredient segment used in laundry detergent formulations. The business currently operates under BASF’s Care Chemicals division. While the companies have not disclosed financial terms, they expect to complete the transaction in the first quarter of 2026, subject to customary closing conditions.
Transaction Scope Includes Swiss Production and Workforce
The agreement covers BASF’s international optical brightening agent business, including the production facility in Monthey, Switzerland, and approximately 80 employees. Through this transfer, Catexel will assume responsibility for operations, manufacturing, and future development of the business.
Divestment Supports BASF’s Portfolio Transformation
This divestment aligns with BASF’s ongoing strategic portfolio transformation. As part of its “Winning Ways” strategy, BASF continues to actively manage its business portfolio and sharpen its strategic focus. Mary Kurian, President, Care Chemicals at BASF, said, “Through active portfolio management and prioritization, we are creating the right conditions for long-term value creation. With Catexel as a dedicated and focused new owner, the optical brightening agent business can continue to grow and fully realize its potential.”
Catexel Expands Care Chemicals Portfolio
Catexel operates as the Care Chemicals platform of the International Chemical Investors Group (ICIG). It specializes in high-quality specialty chemicals for detergents and cleaning products, personal care, and industrial applications. By acquiring BASF’s optical brightening agent business, Catexel is expanding its product portfolio. The move also strengthens its position as a reliable partner for customers seeking premium detergent ingredients.
Dr. Alexander Snell, President and CEO of Catexel, added, “The transaction marks another important step in Catexel’s growth journey. With a state-of-the-art production facility and a highly experienced team in Switzerland, we are building a strong foundation for innovation and future expansion. The acquisition reinforces our commitment to customers and advances our long-term strategic direction”.
Strengthening Long-Term Market Position
As per the press release, overall, the transaction underscores BASF’s disciplined approach to portfolio optimization while enabling Catexel to scale its care chemicals platform. As a result, both companies are positioning themselves for focused growth and long-term value creation in their respective markets.
